Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans?

Vagally-mediated hyperinsulinemia is a common abnormality in various rodent models of genetic and hypothalamic obesity that have a high propensity for type 2 diabetes. We hypothesized that Pima Indians, a population with a high prevalence of hyperinsulinemia, obesity, and type 2 diabetes also have an increased parasympathetic drive to the pancreas. To test this, we measured plasma concentrations of insulin and pancreatic polypeptide (PP), a surrogate marker of pancreatic vagal tone, in lean and obese Pima Indian and Caucasian children (n = 43, 26P/17C, 7 +/- 1 y) and adults (n = 92, 61P/31C, 31 +/- 5 y). Pima Indian children had approximately 2-fold higher fasting insulin and 57% higher fasting PP concentrations than age- and sex-matched Caucasian children (P < .05). Although there was no difference in fasting PP concentration between Pima Indian and Caucasian adults, in response to a mixed meal, Pima Indians had a 51% higher early (30 minutes) PP concentration and 2-fold higher early insulin concentration than Caucasians (P < .05). PP concentrations at 60 minutes and 120 minutes after the meal were also markedly higher in both lean and obese Pima Indians compared with lean and obese Caucasians. These results suggest that Pima Indians may have an increased parasympathetic drive to the pancreas, which could lead to a primary hypersecretion of insulin and contribute to their high propensity for obesity and diabetes, as is the case in various rodent models of obesity.

[1]  E. Ravussin,et al.  Fasting Hyperinsulinemia Is a Predictor of Increased Body Weight Gain and Obesity in Pima Indian Children , 1997, Diabetes.

[2]  R. Townsend,et al.  Early phase insulin infusion and muscarinic blockade in obese and lean subjects. , 1999, The American journal of physiology.

[3]  M. Feinglos,et al.  Muscarinic Stimulation and Antagonism and Glucoregulation in Nondiabetic and Obese Hyperglycemic Mice , 1989, Diabetes.

[4]  S A BERSON,et al.  Immunoassay of endogenous plasma insulin in man. , 1996, The Journal of clinical investigation.

[5]  J. Felber,et al.  Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects. , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  M. Bondi,et al.  Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects , 1997, International Journal of Obesity.

[7]  P. Bennett,et al.  Insulinemia in Children at Low and High Risk of NIDDM , 1993, Diabetes Care.

[8]  T. Schwartz,et al.  Pancreatic polypeptide: a hormone under vagal control. , 1983, Gastroenterology.

[9]  E. Jéquier,et al.  Effects of muscarinic blockade on insulin secretion and on glucose‐induced thermogenesis in lean and obese human subjects , 1991, European journal of clinical investigation.

[10]  R. Hanson,et al.  Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? , 1994, BMJ.

[11]  B. Jeanrenaud,et al.  A role for the vagus nerve in the etiology and maintenance of the hyperinsulinemia of genetically obese fa/fa rats. , 1985, International journal of obesity.

[12]  R. Pratley,et al.  Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. , 1999, Obesity research.

[13]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[14]  P. B. Eveleth,et al.  Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .

[15]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[16]  G. Greeley,et al.  Protein Meal‐Stimulated Pancreatic Polypeptide Secretion in Prader–Willi Syndrome of Adults , 1989, Pancreas.

[17]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[18]  R. Sicree,et al.  Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr , 1987, Diabetes.

[19]  G. Bray,et al.  Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose. , 1983, The American journal of physiology.

[20]  G. Stalla,et al.  Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man. , 2003, British journal of clinical pharmacology.

[21]  G. Bray,et al.  Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions. , 1986, Endocrinology.

[22]  J. Rehfeld,et al.  PANCREATIC-POLYPEPTIDE RESPONSE TO FOOD IN DUODENAL-ULCER PATIENTS BEFORE AND AFTER VAGOTOMY , 1976, The Lancet.

[23]  J. Holst,et al.  Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. , 1983, International journal of obesity.

[24]  W. Rohde,et al.  Malformations of Hypothalamic Nuclei in Hyperinsulinemic Offspring of Rats with Gestational Diabetes , 1999, Developmental Neuroscience.

[25]  T. Schwartz.  Pancreatic polypeptide: a unique model for vagal control of endocrine systems. , 1983, Journal of the autonomic nervous system.

[26]  S. Lillioja,et al.  Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. , 1991, The Journal of clinical endocrinology and metabolism.

[27]  R. Alemzadeh,et al.  Beneficial effect of diazoxide in obese hyperinsulinemic adults. , 1998, The Journal of clinical endocrinology and metabolism.

[28]  J. Kral,et al.  Truncal vagotomy in morbid obesity. , 1981, International journal of obesity.

[29]  P. Bennett,et al.  Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. , 1990, Diabetes/metabolism reviews.

[30]  W. Rohde,et al.  Syndrome X-like alterations in adult female rats due to neonatal insulin treatment. , 1998, Metabolism: clinical and experimental.

[31]  J. Walsh,et al.  Effect of atropine on vagal release of gastrin and pancreatic polypeptide. , 1979, The Journal of clinical investigation.

[32]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[33]  E. Ravussin,et al.  Use of dual-energy X-ray absorptiometry in obese individuals. , 1995, The American journal of clinical nutrition.

[34]  G. Bray,et al.  The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. , 1977, Endocrinology.

[35]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[36]  L. Pénicaud,et al.  In vivo metabolic changes as studied longitudinally after ventromedial hypothalamic lesions. , 1986, The American journal of physiology.

[37]  L. Howard,et al.  TRUNCAL VAGOTOMY IN HYPOTHALAMIC OBESITY , 1983, The Lancet.

[38]  B. Jeanrenaud,et al.  Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. , 1985, Endocrinology.

[39]  B. Jeanrenaud,et al.  The origins and role of efferent vagal nuclei in hyperinsulinemia in hypothalamic and genetically obese rodents. , 1983, Journal of the autonomic nervous system.

[40]  C. Bogardus,et al.  A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. , 2000, Diabetes.

[41]  H. Berthoud,et al.  Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. , 1979, Endocrinology.

[42]  R B Mazess,et al.  Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. , 1990, The American journal of clinical nutrition.

[43]  W. Bauman,et al.  Pancreatic polypeptide in Pima Indians: the influence of obesity and diabetes. , 1985, Metabolism: clinical and experimental.